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The generation of the human iPSC line, LND554SV.3, was carried out
using non-integrative Sendai viruses containing the reprogramming
factors, OCT3/4, SOX2, cMYC, KLF4 (Takahashi et al., 2007). For this
purpose, ﬁbroblasts from a described patient with Leigh syndrome, an
inherited devastating neurodegenerative disorder, were employed
(Monlleo-Neila et al., 2013). The patient's ﬁbroblasts carried a
heteroplasmic mitochondrial DNA (mtDNA) mutation in the MT-ND5
gene (m.13513GNA; p.D393N) with a mutant mtDNA load of 55%. The
presence of thismutation in the iPSCswas conﬁrmed (Fig. 1A). Interest-
ingly, the percentage of mutant mtDNA in the LND554SV.3 line was
only 32% due to spontaneous segregation of the heteroplasmic mtDNA
content (Fig. 1A). LND554SV.3 iPSC colonies displayed a typical ES-like
colony morphology and growth behavior (Fig. 1B) and they stained
positive for alkaline phosphatase activity (Fig. 1C). We conﬁrmed the
clearance of the vectors and the exogenous reprogramming factor
genes by RT-PCR after eight culture passages (Fig. 1D). The endogenous
expression of the pluripotency associated transcription factors OCT4,
SOX2, KLF4, NANOG, CRIPTO and REX1 was evaluated by quantitative//creativecommons.org/licenses/by-nc-nd/4.0/).
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65T. Galera et al. / Stem Cell Research 16 (2016) 63–66real time polymerase chain reaction (qPCR) (Fig. 1E). Immunoﬂuores-
cence analysis revealed expression of transcription factors OCT4,
NANOG, SOX2 and surface markers SSEA3, SSEA4, TRA1-60 and TRA1-81
characteristics of pluripotent ES cells (Fig. 1F). Promoters of the
pluripotency associated genes, OCT4 and NANOG, heavily methylated in
the original ﬁbroblasts were almost demethylated in the LND554SV.3
line suggesting an epigenetic reprogramming to pluripotency (Fig. 1G).
The iPSC line has been adapted to feeder-free culture conditions and
displays a normal karyotype (46, XY) after more than twenty culture
passages (Fig. 1H). We also conﬁrmed by DNA ﬁngerprinting analysis
that the line LND554SV.3 was derived from the patient's ﬁbroblasts
(Fig. 1I). Finally, the capacity of the generated iPSC line to differentiate
into the three germ layers (endoderm, mesoderm and ectoderm) was
tested in vitro using an embryoid body based assay (Fig. 1J).
Materials and methods
Non-integrative reprogramming of Leigh ﬁbroblasts into iPSC
All the experimental protocols included in the present studywere ap-
provedby the Institutional Ethical Committee of theAutonomaUniversity
of Madrid according to Spanish and European Union legislation. Human
ﬁbroblasts from a described patient presenting with Leigh syndrome
caused by a heteroplasmic mutation in the mtDNA (m.13513GNA;
p.D393N)were kindly provided by Dr. FrancinaMunell from the Hospital
Universitario Vall d'Hebron (Barcelona, Spain) (Monlleo-Neila et al.,
2013). These ﬁbroblasts were reprogrammed using the CytoTune-iPS
2.0 Sendai reprogramming kit following the instructions of the manufac-
turer. After eight passages of the iPSC line, silencing of the exogenous
reprogramming factor genes and Sendai virus genome was conﬁrmed
by RT-PCR following the manufacturer's instructions. LND554SV.3 was
maintained and expandedboth on feeder layers and on feeder-free layers.
In the ﬁrst case, irradiated human ﬁbroblast feeders with ES medium
containing: Knockout DMEM (Life Technologies), Knockout serum
replacement 20% (Life Technologies), MEM non-essential amino acids
solution 1X (Life Technologies), GlutaMAX 1X (Life Technologies),
β-mercaptoethanol (100 μM), penicillin/streptomycin 1X (Life Technol-
ogies) and bFGF (4 ng/ml) (Miltenyi Biotec) were used. Subsequently,
LND554SV.3 was adapted and cultured in feeder-free conditions on
matrigel (354277, Corning)withmTeSR1medium(StemCell) following
the recommendations of the manufacturer. For the propagation of
the line, both enzymatic (dispase, collagenase IV and accumax) and
mechanical procedures have been used.
Phosphatase alkaline analysis
The iPSC line LND554SV.3 was seeded on a feeder layer plate. After
six days direct phosphatase alkaline activity was determined using the
phosphatase alkaline blue membrane substrate solution kit (Sigma,
AB0300) following the instructions of the manufacturer.
Mutation analysis
Total DNA from the patient'sﬁbroblasts and iPSCswas extracted using
a standard phenol-chloroform protocol. Subsequently, ampliﬁcation by
PCR of a mtDNA region containing the m.13513GNA mutation was car-
ried out using the following primers: mt-20F: 5′ ATCTGTACCCACGCCT
TC 3′ and mt-20R: 5′ AGAGGGGTCAGGGTTGATTC 3′. Following PCRFig. 1.Molecular and functional characterization of the LND554SV.3 iPSC line. A. Electropherogra
line. B. Typical ES-like colony morphology of the LND554SV.3 iPSC line. C. Positive phosphatase
reprogramming factor genes. E. QPCR showing the expression of thepluripotency associatedma
expression of typical pluripotent ES cellmarkers such as the transcription factors OCT4, NANOG,
Bisulﬁte pyrosequencing of the OCT4 and NANOG promoters. The promoters of the transcrip
Karyotype analysis. LND554SV.3 has a normal karyotype (46, XY). I. DNA ﬁngerprinting analys
in vitro differentiation assays. LND554SV.3 differentiates into all three germ layers, demonstrate
mesoderm staining.ampliﬁcation, direct sequencing of amplicons was performed on both
strands in an ABI 3730 sequencer (Applied Biosystems; Foster City, CA)
using a dye terminator cycle sequencing kit (Applera, Rockville, MD).
qPCR analyses
Total mRNAwas isolated using TRIZOL and 1 μg was used to synthe-
size cDNAusing theQuantitect reverse transcription cDNA synthesis kit.
One μl of the reaction was used to quantify by qPCR the expression of
the endogenous pluripotency associated genes (OCT4, SOX2, KLF4,
NANOG, CRIPTO and REX1). Primer sequences were described by Aasen
et al. (2008). All the expression values were normalized to the GAPDH
housekeeping gene. Plots are representative of at least three indepen-
dent experiments.
Bisulﬁte pyrosequencing
Bisulﬁte modiﬁcation of genomic DNA was performed with the
EZ DNA Methylation-Gold kit (Zymo Research) following the
manufacturer's instructions. The set of primers for PCR ampliﬁcation
and sequencing of NANOG and OCT4 were designed using the software
PyroMark Assay Design (version 2.0.01.15; Qiagen): Forward-NANOG
(5′-TAT TGG GAT TAT AGG GGT GGG TTA-3′), Reverse-NANOG (5′-
[Btn]-CCC AAC AAC AAA TAC TTC TAA ATT CAC-3′), and sequencing
primer S-NANOG (5′-ATA GGG GTG GGT TAT-3′); Forward-OCT4_prox
(5′-GGG GTT AGA GGT TAA GGT TAG TG-3′), Reverse-OCT4_prox
(5′-[Btn]-ACC CCC CTA ACC CAT CAC-3′), and sequencing primer S-
OCT4_prox (5′-GGG GTT GAG TAG TTT-3′); Forward-OCT4_dist (5′-TTT
TTG TGG GGG ATT TGT ATT GA-3′), Reverse-OCT4_dist (5′-[Btn]-AAA
CTA CTC AAC CCC TCT CT-3′), and sequencing primer S-OCT4_dist
(5′-ATT TGT ATT GAG GTT TTG GA-3′). PCR was performed with primers
biotinylated to convert the PCR product to single-stranded DNA
templates, using the Vacuum Prep Tool. After PCR ampliﬁcation, pyrose-
quencing reactions and methylation quantiﬁcation were performed
using PyroMark Q24 reagents, equipment and software (version 2.0.6;
Qiagen), according to the manufacturer's instructions.
Karyotype analysis
Karyotype analyses of the iPSC line were carried out using cells
with more than twenty culture passages. These cells were processed
using standard cytogenetic techniques. Brieﬂy, cells were treated
with 10μg/mL of Colcemid (Gibco) for 90 min at 37 °C, trypsinized,
treated with hypotonic solution KCl 0.075M, and ﬁxed with Carnoy's
ﬁxative. Cells were then dropped on a microscope glass slide and
dried. Metaphase cells were G banded using Wright staining. At
least 20 metaphases were karyotyped.
Immunoﬂuorescence analysis
Cells were grown on 0.1% gelatin-coated P35 culture plates (81156,
Ibidi) and ﬁxed with 4% paraformaldehyde. The following antibodies for
the staining were used: TRA-1-60 (Millipore; MAB4360; 1:150); TRA-1-
81 (Millipore; MAB4381; 1:150); SOX2, (Thermo Scientiﬁc; PA1-16968;
1:100); NANOG (R&D Systems; AF1997; 1:25); SSEA-4 (Millipore;
MAB4304; 1:10); SSEA-3 (Millipore; MAB4303; 1:10); OCT4 (Santa
Cruz Biotechnology; Sc-5279; 1:100); neuron-speciﬁc class III beta-
tubulin (TUJ1) (Sigma, T8660, 1:300), α-fetoprotein (AFP) (Sigma,ms showing them.13513GNAmutation in the patient'sﬁbroblasts and in the LND554SV.3
alkaline staining. D. RT-PCR for detecting the clearance of the vectors and the exogenous
rkersNANOG,OCT4, SOX2,KLF4, CRIPTO andREX1. F. Immunoﬂuorescence analysis showing
SOX2 and the surfacemarkers SSEA3, SSEA4, TRA1-60 and TRA1-81; scale bars: 300 μm. G.
tion factors, OCT4 and NANOG were almost demethylated in the generated iPSC line. H.
is showing that LND554SV.3 comes from the patient's ﬁbroblasts. J. Embryoid body based
d by positive AFP endoderm staining (l), positive TUJ1 ectoderm staining and positive SMA
66 T. Galera et al. / Stem Cell Research 16 (2016) 63–66WH0000174M1, 1:300), smooth muscle alpha actin (SMA) (Sigma,
A2547, 1:400). Secondary antibodies used were all from the Alexa Fluor
Series (1:500) or from Jackson Immunoresearch (Cy2, 1:50; Cy3, 1:250).
Images were taken using a Zeiss confocal microscope.
In vitro differentiation assay
The in vitro pluripotency capacity of the iPSC line was tested by
spontaneous embryoid body differentiation. For this purpose, iPSCs
from a P100 plate with 80% of conﬂuency were dissociated into a single
cell suspension with accumax (SCR006,Millipore) and resuspended in
12 ml of mTeSR1 medium (Stemcell). Embryoid body formation was
induced by seeding 120 μl of the iPSC suspension in each well of
96-well v-bottom low attachment plates and centrifuging the plates at
800 g for 10 min to aggregate the cells. After 2–3 days the embryoid
bodies were transferred to an untreated P60 culture plate for 2–
4 days. Subsequently, the embryoid bodies were transferred to 0.1%
gelatin-coated P35 culture plates (81156, Ibidi) and cultured in differen-
tiation medium (DMEM F12 supplemented with 20% fetal bovine
serum, 2 mM glutamine, 0.1 mM β-mercaptoethanol, 1X non-essential
amino acids and 1X penicillin–streptomycin, all from Invitrogen) for
2–3 weeks to allow spontaneous endoderm formation. For mesoderm
differentiation, iPSCs were maintained for 2–3 weeks in differentiation
medium supplemented with 100 μM ascorbic acid (A4403, Sigma-
Aldrich). For ectoderm differentiation, embryoid bodies were trans-
ferred to matrigel coated P35 culture plates and cultured in a special
differentiation medium containing (50% DMEM F12, 50% neurobasal
medium, 1X GlutaMAX, 1X penicillin/streptomycin, non-essential
aminoacids, 0.1 mM 2-mercaptoethanol, 1X N2 supplement and 1X
B27 supplement, all from Invitrogen). In all the cases, the medium was
changed every other day.
DNA ﬁngerprinting analysis
For DNA ﬁngerprinting analysis, highly polymorphic regions
containing short tandem repeated sequences of DNA have beenevaluated. For this purpose, the following markers (D13S317, D7S820,
VWA,D8S1179, D21S11, D19S433, D2S1338 and amelogenin for sex de-
termination) have been ampliﬁed by PCR and analyzed by ABI PRISM
3100 Genetic analyzer and Peak Scanner v3.5 (Applied Biosystems).
Primer sequences and PCR conditions are available upon request.
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